Stockscreener 앱 받기
1.15
3.36%
-0.04
시간 외 거래:
1.15
전일 마감가:
$1.19
열려 있는:
$1.18
하루 거래량:
1.19M
Relative Volume:
0.91
시가총액:
$112.18M
수익:
$1.20M
순이익/손실:
$-47.60M
주가수익비율:
-1.4544
EPS:
-0.7907
순현금흐름:
$-27.78M
1주 성능:
-10.85%
1개월 성능:
-13.53%
6개월 성능:
+123.34%
1년 성능:
-21.77%
1일 변동 폭
$1.10
$1.18
1주일 범위
$1.10
$1.365
52주 변동 폭
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
명칭
Rani Therapeutics Holdings Inc
전화
(408) 457-3700
주소
2051 RINGWOOD AVENUE, SAN JOSE
Compare RANI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
1.15 | 116.09M | 1.20M | -47.60M | -27.78M | -0.7907 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-02 | 개시 | Oppenheimer | Outperform |
| 2024-06-14 | 개시 | Maxim Group | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2022-10-11 | 개시 | UBS | Buy |
| 2022-07-27 | 개시 | H.C. Wainwright | Buy |
| 2022-06-13 | 개시 | Wedbush | Outperform |
모두보기
Rani Therapeutics Holdings Inc 주식(RANI)의 최신 뉴스
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Rani Therapeutics Holdings Inc (RANI) - MSN
Aug Momentum: Can Rani Therapeutics Holdings Inc navigate macro headwinds2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
RANI SEC FilingsRani Therapeutics Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Rani Therapeutics Holdings Inc. (RANI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Rani Therapeutics Hldgs (RANI) Stock Analysis Report | Financials & Insights - Benzinga Japan
RANI Stock Price, Quote & Chart | RANI THERAPEUTICS HOLDINGS-A (NASDAQ:RANI) - ChartMill
US Market Wrap: Will Rani Therapeutics Holdings Inc outperform during market rallies2026 Institutional Moves & High Win Rate Trade Tips - baoquankhu1.vn
What is the next catalyst for Rani Therapeutics Holdings Inc2026 Market WrapUp & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Maxim Group Keeps Their Buy Rating on Rani Therapeutics Holdings (RANI) - The Globe and Mail
What is Rani Therapeutics Holdings Incs revenue forecastTrade Analysis Report & Low Risk Growth Stock Ideas - baoquankhu1.vn
Rani Therapeutics Holdings, Inc.Class A Common Stock (Nasdaq:RANI) Stock Quote - The Chronicle-Journal
RANI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
RANIRani Therapeutics Holdings, Inc. Latest Stock News & Market Updates - Stock Titan
Bank Watch: What dividend growth rate does Deswell Industries Inc offerTrend Reversal & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Can Rani Therapeutics Holdings Inc. reach all time highs this year2025 Market WrapUp & Verified Momentum Watchlists - mfd.ru
Will Rani Therapeutics Holdings Inc. stock outperform growth indexesWeekly Investment Report & High Accuracy Trade Signal Alerts - mfd.ru
Published on: 2026-02-20 14:00:46 - baoquankhu1.vn
Published on: 2026-02-20 04:36:50 - baoquankhu1.vn
Rani Therapeutics (NASDAQ:RANI) Trading 1.6% HigherTime to Buy? - MarketBeat
RANI Should I Buy - Intellectia AI
Will Rani Therapeutics Holdings Inc. outperform during market rallies2025 Big Picture & High Conviction Investment Ideas - mfd.ru
Does Rani Therapeutics Holdings Inc. offer margin of safety2025 Year in Review & Safe Investment Capital Preservation Plans - mfd.ru
Investment firm reports 9.9% stake in Rani Therapeutics (RANI) - Stock Titan
Published on: 2026-02-13 18:32:35 - baoquankhu1.vn
SymBiosis Capital takes 6.5% passive stake in Rani Therapeutics (RANI) Class A - Stock Titan
Is Rani Therapeutics Holdings Inc. stock near bottom after decline2025 Year in Review & Consistent Growth Equity Picks - mfd.ru
Income Plays: What is the next catalyst for Rani Therapeutics Holdings IncWeekly Trade Review & Technical Buy Zone Confirmation - baoquankhu1.vn
Published on: 2026-02-02 11:44:32 - baoquankhu1.vn
Insider Buyers At Rani Therapeutics Holdings Sitting On US$1.3m Profit - simplywall.st
Vanguard discloses 5.23% Rani Therapeutics (RANI) stake in Schedule 13G - Stock Titan
Rani Therapeutics promotes Alireza Javadi to chief technical officer By Investing.com - Investing.com South Africa
Rani Therapeutics Holdings, Inc. Announces Promotion of Alireza Javadi to Chief Technical Officer - marketscreener.com
Rani Therapeutics announces the promotion of Alireza Javadi, Ph.D. to chief technical officer - marketscreener.com
Rani Therapeutics Names Alireza Javadi Chief Technical Officer - Nasdaq
Rani Therapeutics promotes Alireza Javadi to chief technical officer - Investing.com
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer - The Manila Times
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Bear Alert: Does CompoSecure Inc Equity Warrant stock have upside surprise potential2025 Sector Review & Daily Stock Trend Watchlist - baoquankhu1.vn
Published on: 2026-01-24 03:15:13 - baoquankhu1.vn
AI Stocks: Does XBiotech Inc offer margin of safety2025 Macro Impact & Short-Term High Return Ideas - baoquankhu1.vn
Retail investors account for 65% of Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) ownership, while private equity firms account for 17% - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY) - The Globe and Mail
Rani Therapeutics finalizes governance and capital structure changes - MSN
Targets Report: Can Rani Therapeutics Holdings Inc navigate macro headwindsJuly 2025 Chart Watch & Consistent Return Investment Signals - baoquankhu1.vn
Price Action: Can Rani Therapeutics Holdings Inc navigate macro headwinds2025 Technical Patterns & Community Supported Trade Ideas - baoquankhu1.vn
HOKA Shoe Comparison: Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Grip and Outsole Review & quick comparison of popular models - Улправда
Rani Therapeutics Holdings Inc (RANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rani Therapeutics Holdings Inc 주식 (RANI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner |
Oct 21 '25 |
Sale |
2.77 |
4,000,000 |
11,074,000 |
2,379,194 |
| South Cone Investments Limited | 10% Owner |
Oct 20 '25 |
Sale |
2.41 |
1,923,000 |
4,637,314 |
6,379,194 |
1.20%
0.06%
자본화:
|
볼륨(24시간):